Vertex Pharmaceuticals Cash from Operations (Annual) Analysis

Vertex Pharmaceuticals Inc (VRTX)

445.21 +4.57 (+1.04%) USD | NASDAQ | May 17, 16:00

444.93 -0.28 (-0.06%) After-Hours: 06:26

Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 1991. Upgrade now.

Date	Value
December 31, 2023	3.537B
December 31, 2022	4.130B
December 31, 2021	2.644B
December 31, 2020	3.254B
December 31, 2019	1.569B
December 31, 2018	1.270B
December 31, 2017	844.94M
December 31, 2016	236.10M
December 31, 2015	-365.43M
December 31, 2014	-573.11M
December 31, 2013	-60.67M
December 31, 2012	267.84M
December 31, 2011	143.74M
December 31, 2010	-635.44M
December 31, 2009	-427.59M
December 31, 2008	-226.48M
December 31, 2007	-252.48M

Date	Value
December 31, 2006	-22.48M
December 31, 2005	-172.05M
December 31, 2004	-142.16M
December 31, 2003	-167.62M
December 31, 2002	-79.54M
December 31, 2001	-7.047M
December 31, 2000	-12.71M
December 31, 1999	-31.80M
December 31, 1998	-31.10M
December 31, 1997	-9.40M
December 31, 1996	-40.30M
December 31, 1995	-16.00M
December 31, 1994	-14.70M
December 31, 1993	8.60M
December 31, 1992	-5.30M
December 31, 1991	-2.50M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

1.569B

Minimum

2019

4.130B

Maximum

2022

3.027B

Average

3.254B

Median

2020

Cash from Operations (Annual) Benchmarks